Economic Burden of Obesity-Related Comorbidities in Turkey

YİĞİT, ARZU; YİĞİT, Vahit

Economic Burden of Obesity-Related Comorbidities in Turkey

Arzu YİĞİT, (Süleyman Demirel Üniversitesi, İktisadi ve idari Bilimlar Fakltesi, Sağlık Yönetimi Bölümü, Isparta, Türkiye)

Vahit YİĞİT (Süleyman Demirel Üniversitesi, İktisadi ve idari Bilimlar Fakltesi, Sağlık Yönetimi Bölümü, Isparta, Türkiye)

Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi

6 2

Yıl: 2019 Cilt: 8 Sayı: 3 Sayfa Aralığı: 223 - 230 Metin Dili: İngilizce İndeks Tarihi: 02-04-2020

Economic Burden of Obesity-Related Comorbidities in Turkey

Öz:

Obesity and obesity-related diseases are theleading cause of death worldwide, and mortality andmorbidities they cause are important public healthproblems. The purpose of this study, obesity-relatedcomorbidities is to analyze the economic burden for2004 and 2015 in Turkey. The most important of themethods used to study the burden of disease is theDisability-Adjusted Life Years (DALYs) approach.DALY and gross domestic product (GDP) per capitawere used to estimate the economic burden of obesity.Obesity and related DALYs values were taken fromthe "Turkey Burden of Disease Study" published bythe Ministry of Health. The economic burden ofobesity-causing diseases has been estimated accordingto DALY methodology. Economic burden of obesityrelated comorbidities to Turkey in 2004 was estimatedto be 4.692.333.776-$. This amounts to 1.20% ofgross domestic product. In 2015, the economic burdenof obesity-related comorbidities is 17.646.245.880- $and 2.45% of gross domestic product. Given theincrease in obese population, the economic burden ofobesity-related diseases is expected to increase furtherin the coming years. Obesity-related comorbiditiesrepresent a substantial financial burden to the Turkeybudget. Obesity is an important public health problemthat can be treated. In order to use scarce resourcesdevoted to health services more efficiently andeffectively, it is indispensable to considerably reducethe economic burden of obesity in Turkey.

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Türkiye’de Obezite İlişkili Komorbiditelerin Ekonomik Yükü

Öz:

Obezite ve obeziteye bağlı hastalıklar tüm dünyada önde gelen ölüm nedenidir ve neden oldukları mortalite ve morbiditeler önemli bir halk sağlığı sorununu oluşturmaktadır. Bu araştırmanın amacı, Türkiye'de 2004 ve 2015 yılları için obeziteye bağlı komorbiditelerin ekonomik yükünü analiz etmektir. Hastalık yükü çalışmalarında kullanılan yöntemlerden en önemlisi Engelliğe Bağlı Yaşam Yılları (Disability adjusted life years-DALY) yaklaşımıdır. Obezitenin ekonomik yükünü hesaplamak için, DALY ve gayrisafi yurtiçi hasıladan (GSYİH) kişi başına düşen pay verileri kullanılmıştır. Obezite ve buna bağlı komorbiditelerin DALY değerleri, Sağlık Bakanlığı tarafından yayınlanan "Türkiye Hastalık Yükü Çalışması"ndan alınmıştır. Obeziteye neden olan hastalıkların ekonomik yükü DALY metodolojisine göre tahmin edilmiştir. Türkiye’de obezite ilişkili komorbiditelerin ekonomik yükü 2004 yılında 4.692.333.776-$ olarak tahmin edilmiştir. Bu tutar gayri safi yurtiçi hasılasının %1,20’isini oluşturmaktadır. 2015 yılında ise obezite ilişkili komorbiditelerin ekonomik yükü ise 17.646.245.880-$ ve gayri safi yurtiçi hasılasının %2,45’ini oluşturmaktadır. Obez nüfusun artışı dikkate alındığında obeziteye bağlı hastalıkların ekonomik yükününün ilerleyen yıllarda daha da artacağı düşünülmektedir. Obezite ile ilişkili komorbiditeler, Türkiye bütçesine önemli bir mali yük oluşturmaktadır. Obezite tedavi edilebilen önemli bir halk sağlığı problemdir. Sağlık hizmetlerine ayrılan kıt kaynakları daha verimli ve etkin kullanabilmek için, Türkiye’de obezitenin ekonomik yükünü dikkate değer ölçüde düşürmek gerekmektedir.

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Yates, N., Teuner, C. M., Hunger, M., Holle, R., Stark, R., Laxy, M., Wolfenstetter, S. B. (2016). The economic burden of obesity in Germany: results from the population-based KORA studies. Obesity facts, 9 (6), 397-409.
2. Raebel. M. A., Malone. D. C., Conner. D. A., Xu. S., Porter. J. A., Lanty. F. A. (2004). Health services use and health care costs of obese and nonobese individuals. Archives of ınternal medicine, 164 (19), 2135–2140.
3. Lehnert. T., Sonntag. D., Konnopka. A., Riedel-Heller. S., König. H.-H. (2013). Economic costs of overweight and obesity. Best practice & research clinical endocrinology & metabolism, 27 (2), 105–115.
4. Zhao. W., Zhai. Y., Hu. J., Wang. J., Yang. Z., Kong. L., Chen. C. (2008). Economic burden of obesity-related chronic diseases in Mainland China. Obesity reviews, 9 (1), 62–67.
5. Park, J. H., Yoon, S. J., Lee, H., Jo, H. S., Lee, S. I., Kim, Y., Shin, Y. (2006). Burden of disease attributable to obesity and overweight in Korea. International journal of obesity, 30 (11), 1661-1669.
6. Müller-Riemenschneider. F., Reinhold. T., Berghöfer. A., Willich. S. N. (2008). Health-economic burden of obesity in Europe. European journal of epidemiology, 23 (8), 499–509.
7. OECD (2017). Health at a Glance 2017: OECD Indicators. OECD Publishing. Paris.
8. Kim, D. D., Basu, A. (2016). Estimating the medical care costs of obesity in the United States: systematic review, metaanalysis, and empirical analysis. Value in health, 19 (5), 602- 613.
9. Erem. C. (2015). Prevalence of Overweight and Obesity in Turkey. IJC Metabolic & endocrine, 8: 38–41.
10. Kockaya. G., Ergin. G., Atikeler. K., Tatar. M., Ozmen. M., Gorgun. M.,Taskin. M. (2013). Operational cost of obesity surgery for Turkey. Obesity surgery, 23 (8), 1142–1143.
11. WHO. (2009). Global health risks: mortality and burden of disease attributable to selected major risks. WHO Press, Switzerland.
12. Wang. L. Y., Denniston. M., Lee. S., Galuska. D., Lowry. R. (2010). Long-term health and economic impact of preventing and reducing overweight and obesity in adolescence. Journal of adolescent health, 46 (5), 467–473.
13. Buchmueller. T. C., Johar. M. (2015). Obesity and health expenditures: Evidence from Australia. Economics and human biology, 17, 42–58
14. Birmingham. C. L., Muller. J. L., Palepu. A., Spinelli. J. J., Anis. A. H. (1999). The cost of obesity in Canada. Canadian medical association journal, 160 (4), 483–488.
15. Feigin. V. L., Abajobir. A. A., Abate. K. H., Abd-Allah. F., Abdulle. A. M., Abera. S. F., Vos. T. (2017). Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Neurology, 16 (11), 877–897.
16. Specchia. M. L., Veneziano. M. A., Cadeddu. C., Ferriero. A. M., Mancuso. A., Ianuale. C., Ricciardi. W. (2015). Economic impact of adult obesity on health systems: A systematic review. European journal of public health, 25 (2), 255–262
17. Metrics, I. (2013). Evaluation: the global burden of disease: generating evidence, guiding policy. WA: IHME Seattle.
18. The Ministry of Health of Turkey (2006). Turkey Burden of Disease Study (2004). Editör: Ünüvar. N. Mollahaliloglu. S., Yardim. N. Refik Saydam Hygiene Center. School of Public Health. Ankara.
19. Fox-Rushby. J. A. (2002). Disability Adjusted Life Years (DALYs) for decision-making? An overview of the literature. Office of health economic, London.
20. Devleesschauwer B. Havelaar AH. Maertens De Noordhout C. Haagsma JA. Praet N. Dorny P. et al. (2014) Calculating disability-adjusted life years to quantify burden of disease. Int J public health. 59 (3), 565–569.
21. Struijk, E. A., May, A. M., Beulens, J. W., de Wit, G. A., Boer, J. M., Onland-Moret, N. C., Peeters, P. H. (2013). Development of methodology for disability-adjusted life years (DALYs) calculation based on real-life data. PLoS one, 8 (9), e74294.
22. Sassi. F. (2006). Calculating QALYs. comparing QALY and DALY calculations. Health policy and planning, 21 (5), 402– 408.
23. Rios-Diaz. A. J., Lam. J., Ramos. M. S., Moscoso. A. V., Vaughn. P., Zogg. C. K., Caterson. E. J. (2016). Global patterns of QALY and DALY use in surgical cost-utility analyses: A systematic review. PLoS one, 11 (2), 1–13.
24. Whitehead. S. J., Ali. S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British medical bulletin. 96 (1), 5–21.
25. Robberstad. B. (2005). QALY vs DALY vs LYs gained: What are the difference and what difference do they make for health care priority setting? Norsk epidemiologi. 15(2), 183– 191.
26. Ng. M., Fleming. T., Robinson. M., Thomson. B., Graetz. N., Margono. C., Gakidou. E. (2014). Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 384 (9945), 766–781.
27. WHO (2017). Disability-adjusted life year. http://www.who.int/gho/. date of access: 11.12.2017
28. Wiki Commons (2017). https://commons.wikimedia.org/ wiki/File: DALY_.png. date of access: 10.10.2017
29. Ministry of Health (2013). Moving Life and Healthy Nutrition Program in Turkey. Turkish Public Health Institution. Ankara.
30. Ministry of Health (2014). Role of Obesity Treatment of Obesity Surgery in Turkey. Republic of Turkey Ministry of Health Directorate General for Research, Ankara.
31. Dobbs. R., Sawers. C., Thompson. F., Manyika. J., Woetzel. J., Child. P., Spatharou. A. (2014). Overcoming obesity: An initial economic analysis. McKinsey & Company: www. mckinsey. com/mgi. 1-106, date of access: 11.12.2017
32. OECD (2017). “Obesity Update”. OECD Publishing. Paris. http:// www.oecd.org/els/health-systems/Obesity-Update2017.pdf, date of access: 1.12.2017
33. Shankar. B., Mazzocchi M., Traill WB. (2014). Encyclopedia of health Economics: macroeconomic. Causes and effects of noncommunicable disease: The case of diet and obesity. Editor: Gulyer. A.J. Netherlands.
34. Chooi, Y. C., Ding, C., Magkos, F. (2019). The epidemiology of obesity. Metabolism, 92, 6-10.
35. Yusefzadeh, H., Rahimi, B., Rashidi, A. L. I. (2019). Economic burden of obesity: A systematic review. Soc Health Behav, 2, 7-12.
36. Katzmarzyk, P. T., Janssen, I. (2004). The economic costs associated with physical inactivity and obesity in Canada: an update. Canadian journal of applied physiology, 29(1), 90-115.
37. Borg, S., Persson, U., Ödegaard, K., Berglund, G., Nilsson, J. Å., & Nilsson, P. M. (2005). Obesity, survival, and hospital costs—findings from a screening project in Sweden. Value in Health, 8 (5), 562-571.
38. Finkelstein, E. A., Ruhm, C. J., & Kosa, K. M. (2005). Economic causes and consequences of obesity. Annu. Rev. Public Health, 26, 239-257.
39. Konnopka, A., Bödemann, M., König, H. H. (2011). Health burden and costs of obesity and overweight in Germany. The European journal of health economics, 12 (4), 345-352.
40. Thompson, D., Wolf, A. M. (2001). The medical‐care cost burden of obesity. Obesity reviews, 2 (3), 189-197.
41. Popkin, B. M., Kim, S., Rusev, E. R., Du, S., Zizza, C. (2006). Measuring the full economic costs of diet, physical activity and obesity‐related chronic diseases. Obesity reviews, 7 (3), 271-293.
42. Kang, J. H., Jeong, B. G., Cho, Y. G., Song, H. R., & Kim, K. A. (2011). Socioeconomic costs of overweight and obesity in Korean adults. Journal of Korean medical science, 26 (12), 1533-1540.
43. Lee, J. E., Nam, C. M., Lee, S. G., Park, S., Kim, T. H., & Park, E. C. (2019). The economic burden of cancer attributable to obesity in Korea: A population‐based cohort study. European journal of cancer care, e13084, 1-10.

APA	YİĞİT A, YİĞİT V (2019). Economic Burden of Obesity-Related Comorbidities in Turkey. , 223 - 230.
Chicago	YİĞİT ARZU,YİĞİT Vahit Economic Burden of Obesity-Related Comorbidities in Turkey. (2019): 223 - 230.
MLA	YİĞİT ARZU,YİĞİT Vahit Economic Burden of Obesity-Related Comorbidities in Turkey. , 2019, ss.223 - 230.
AMA	YİĞİT A,YİĞİT V Economic Burden of Obesity-Related Comorbidities in Turkey. . 2019; 223 - 230.
Vancouver	YİĞİT A,YİĞİT V Economic Burden of Obesity-Related Comorbidities in Turkey. . 2019; 223 - 230.
IEEE	YİĞİT A,YİĞİT V "Economic Burden of Obesity-Related Comorbidities in Turkey." , ss.223 - 230, 2019.
ISNAD	YİĞİT, ARZU - YİĞİT, Vahit. "Economic Burden of Obesity-Related Comorbidities in Turkey". (2019), 223-230.

APA	YİĞİT A, YİĞİT V (2019). Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 8(3), 223 - 230.
Chicago	YİĞİT ARZU,YİĞİT Vahit Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 8, no.3 (2019): 223 - 230.
MLA	YİĞİT ARZU,YİĞİT Vahit Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, vol.8, no.3, 2019, ss.223 - 230.
AMA	YİĞİT A,YİĞİT V Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi. 2019; 8(3): 223 - 230.
Vancouver	YİĞİT A,YİĞİT V Economic Burden of Obesity-Related Comorbidities in Turkey. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi. 2019; 8(3): 223 - 230.
IEEE	YİĞİT A,YİĞİT V "Economic Burden of Obesity-Related Comorbidities in Turkey." Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 8, ss.223 - 230, 2019.
ISNAD	YİĞİT, ARZU - YİĞİT, Vahit. "Economic Burden of Obesity-Related Comorbidities in Turkey". Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 8/3 (2019), 223-230.